Innocan Pharma Corp. buy Heisinger
Start price
17.09.21
/
50%
€0.89
Target price
17.09.22
-
Performance (%)
-55.14%
End price
19.05.22
€0.40
Summary
This prediction ended on 19.05.22 with a price of €0.40. The BUY prediction by Heisinger for Innocan Pharma Corp. performed very badly with a performance of -55.14%. Heisinger has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Innocan Pharma Corp. | - | - | - | - |
| iShares Core DAX® | 0,44 % | 5,64 % | 7,81 % | 63,64 % |
| iShares Nasdaq 100 | 1,06 % | 0,28 % | 27,24 % | 88,12 % |
| iShares Nikkei 225® | 1,77 % | 0,41 % | 49,27 % | 83,53 % |
| iShares S&P 500 | 0,37 % | 1,92 % | 22,34 % | 68,75 % |
Comments by Heisinger for this prediction
In the thread Innocan Pharma Corp. diskutieren
Buy Innocan Pharma Corp.

